Clinical Trial Update: Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CDI-31244 in combination with Sofosbuvir and Velpatasvir in chronic hepatitis C has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• CDI-31244
• Sofosbuvir (sofosbuvir)
• Velpatasvir (velpatasvir)

Snippet

Sponsor: Cocrystal Pharma, Inc. | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2021-04-28